Related Experiment Video
Updated: Jun 13, 2025

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
Published on: December 15, 2014
Detection of Contralateral Malignancies on Breast MRI
1Radiology, University of Florida College of Medicine, Gainesville, USA.
Magnetic Resonance Imaging (MRI) significantly improves the detection of contralateral breast cancer missed by mammography (MAM). This early detection via MRI aids in timely treatment and better patient outcomes for synchronous bilateral breast cancer.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Women diagnosed with unilateral breast cancer face an elevated risk of developing simultaneous contralateral breast cancer.
- Early detection of contralateral breast cancer is crucial for preventing additional treatments and improving overall survival rates.
- Despite its benefits, MRI screening for contralateral breast cancer is underutilized after an initial unilateral diagnosis.
Purpose of the Study:
- To retrospectively evaluate the efficacy of breast MRI in detecting contralateral breast cancer in patients already diagnosed with unilateral breast cancer.
- To compare the detection rates of contralateral breast cancer between mammography (MAM) and MRI.
- To assess the impact of MRI-detected contralateral cancers on patient management and treatment.
Main Methods:
- Retrospective chart review of women diagnosed with synchronous bilateral breast cancer between January 2017 and January 2022.
- Analysis of mammography (MAM) and MRI imaging reports to identify contralateral breast cancer.
- Review of surgical pathology reports for histological type and TNM staging of contralateral cancers.
Main Results:
- Mammography (MAM) missed contralateral cancer in 17 cases, of which MRI detected malignancy in 12 cases (70.59%), leading to changes in management.
- The detection rate of contralateral breast cancer by MAM alone was 45.45% (15/33).
- Cancers missed by MAM were predominantly early-stage (T1 or Tis) with no nodal involvement, indicating MRI's potential for detecting occult malignancies.
Conclusions:
- Breast MRI demonstrates superior ability in detecting contralateral breast cancer compared to mammography (MAM).
- MRI significantly increases the detection rate of synchronous contralateral breast cancer, often identifying early-stage disease.
- The utility of MRI in staging and detecting occult contralateral malignancies justifies its cost and should be considered in future clinical practice.
More Related Videos
13:44Detection of Architectural Distortion in Prior Mammograms via Analysis of Oriented Patterns
Published on: August 30, 2013
08:36Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
Published on: March 6, 2014